Trials / Completed
CompletedNCT00291798
Neoadjuvant Endocrinotherapy of Breast Cancer (Mamma Carcinoma) With Exemestane
Neoadjuvant Endocrinotherapy of Mamma Carcinoma With Exemestane
- Status
- Completed
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 98 (planned)
- Sponsor
- Austrian Breast & Colorectal Cancer Study Group · Network
- Sex
- Female
- Age
- 59 Years
- Healthy volunteers
- Not accepted
Summary
The objective of the present clinical investigation is to determine whether hormonal therapy given preoperatively is able to reduce tumor size to an extent that facilitates breast-conserving procedures.
Detailed description
This open, prospective multicenter Phase II pilot trial investigates the efficacy of exemestane, 25 mg once daily over 4 months, in postmenopausal women with primary breast cancer, measured in terms of clinical response
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| PROCEDURE | rate of remission |
Timeline
- Start date
- 2000-09-01
- Completion
- 2009-03-01
- First posted
- 2006-02-15
- Last updated
- 2006-09-19
Locations
11 sites across 1 country: Austria
Source: ClinicalTrials.gov record NCT00291798. Inclusion in this directory is not an endorsement.